Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: Prospective pilot study

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Hurst, John R ^a   Donaldson, Gavin C ^a   Quint, Jennifer K ^a   Goldring, James J P ^a   Patel, Anant R C ^a   Wedzicha, Jadwiga A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; OXYGEN;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEART RATE; HUMAN; MALE; OXYGEN SATURATION; PEAK EXPIRATORY FLOW; PILOT STUDY; PROSPECTIVE STUDY; PULSE OXIMETRY; SENSITIVITY AND SPECIFICITY; AMBULATORY MONITORING; BLOOD; DAILY LIFE ACTIVITY; METHODOLOGY; OXIMETRY; PATHOPHYSIOLOGY;

ACTIVITIES OF DAILY LIVING; AGED; FEMALE; HEART RATE; HUMANS; MALE; MONITORING, AMBULATORY; OXIMETRY; OXYGEN; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77957998357     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-52     Document Type: Article

References (21)

1. Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease Updated. December 2009. Available at: last accessed 10th February 2010, Global Initiative for Chronic Obstructive Lung Disease., http://www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=2180
2. Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2004, 169:1298-1303. 10.1164/rccm.200310-1443OC, 14990395.
3. Jones P, Higenbottam T. Quantifying of severity of exacerbations in chronic obstructive pulmonary disease: adaptations to the definition to allow quantification. Proc Am Thorac Soc 2007, 4:597-601. 10.1513/pats.200707-115TH, 18073389.
4. Hurst JR, Perera WR, Wilkinson TMA, Donaldson GC, Wedzicha JA. Systemic and Upper and Lower Airway Inflammation at Exacerbation of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2006, 173:71-78. 10.1164/rccm.200505-704OC, 16179639.
5. Hurst JR, Donaldson GC, Perera WR, Wilkinson TMA, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA. Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2006, 174:867-874. 10.1164/rccm.200604-506OC, 16799074.
6. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1608-1613.
7. Calverley P, Pauwels R, Löfdahl CG, Svensson K, Higenbottam T, Carlsson LG, Ståhl E. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 2005, 26:406-413. 10.1183/09031936.05.00143404, 16135720.
8. McKinstry B, Pinnock H, Sheikh A. Telemedicine for management of patients with COPD?. Lancet 2009, 374:672-673. 10.1016/S0140-6736(09)61542-7, 19716948.
9. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation of quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422.
10. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000, 55:114-120. 10.1136/thorax.55.2.114, 1745686, 10639527.
11. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax
12. Donaldson GC, Wilkinson TMA, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2005, 171:446-452. 10.1164/rccm.200408-1054OC, 15579723.
13. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
14. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:358-364.
15. Soler-Cataluña JJ, Martínez-García M, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60:925-931. 10.1136/thx.2005.040527, 1747235, 16055622.
16. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000, 117:5S-9S. 10.1378/chest.117.2_suppl.5S, 10673466.
17. Hurst JR, Donaldson GC, Quint JK, Goldring JJP, Baghai-Ravary R, Wedzicha JA. Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2009, 179:369-374. 10.1164/rccm.200807-1067OC, 19074596.
18. Commission of the European Communities, Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on telemedicine for the benefit of patients, healthcare systems and society. last accessed 9th February 2010., http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0689:FIN:EN:PDF
19. Hurst JR, Wedzicha JA. What is (and what is not) an exacerbation of COPD: thoughts from the new GOLD guidelines. Thorax 2007, 62:198-199. 10.1136/thx.2007.077883, 2117162, 17329557.
20. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Löfdahl CG, Pauwels RA, Ullman A. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999, 160:594-599.
21. Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008, 177:396-401. 10.1164/rccm.200708-1290OC, 18048806.